Aruga A - Search Results

1

Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma.

Shimizu K, Kotera Y, Aruga A, Takeshita N, Takasaki K, Yamamoto M. Shimizu K, et al. Among authors: aruga a. J Hepatobiliary Pancreat Sci. 2012 Mar;19(2):171-8. doi: 10.1007/s00534-011-0437-y. J Hepatobiliary Pancreat Sci. 2012. PMID: 21874278

2

Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma.

Matsumura N, Yamamoto M, Aruga A, Takasaki K, Nakano M. Matsumura N, et al. Among authors: aruga a. Cancer. 2002 Mar 15;94(6):1770-6. doi: 10.1002/cncr.10398. Cancer. 2002. PMID: 11920540 Free article.

3

[Dendritic cell vaccine for intrahepatic cholangio cellular carcinoma--a study of relationship between immuno-reaction and clinical outcome].

Kotera Y, Kougen Y, Aruga A, Yamamoto M. Kotera Y, et al. Among authors: aruga a. Gan To Kagaku Ryoho. 2009 Nov;36(12):1964-6. Gan To Kagaku Ryoho. 2009. PMID: 20037292 Japanese.

4

Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma.

Shimizu K, Kotera Y, Aruga A, Takeshita N, Katagiri S, Ariizumi S, Takahashi Y, Yoshitoshi K, Takasaki K, Yamamoto M. Shimizu K, et al. Among authors: aruga a. Hum Vaccin Immunother. 2014;10(4):970-6. doi: 10.4161/hv.27678. Epub 2014 Jan 13. Hum Vaccin Immunother. 2014. PMID: 24419174 Free PMC article. Clinical Trial.

5

Phase I clinical trial of multiple-peptide vaccination for patients with advanced biliary tract cancer.

Aruga A, Takeshita N, Kotera Y, Okuyama R, Matsushita N, Ohta T, Takeda K, Yamamoto M. Aruga A, et al. J Transl Med. 2014 Mar 7;12:61. doi: 10.1186/1479-5876-12-61. J Transl Med. 2014. PMID: 24606884 Free PMC article. Clinical Trial.

6

[Cellular immunotherapy against metastatic lung cancer].

Aruga A, Tanigawa K, Shimizu K, Sudo T, Takasaki K. Aruga A, et al. Nihon Rinsho. 2002 May;60 Suppl 5:621-4. Nihon Rinsho. 2002. PMID: 12101749 Review. Japanese. No abstract available.

7

[Combined cell therapy by using dendritic cells, T-cells and NK cells to human polymorphic cancer].

Matsushita N, Kobayashi Y, Tanaka Y, Nakao M, Shimizu K, Takeshita N, Tanigawa K, Aruga A. Matsushita N, et al. Among authors: aruga a. Gan To Kagaku Ryoho. 2004 Oct;31(11):1655-8. Gan To Kagaku Ryoho. 2004. PMID: 15553674 Japanese.

8

OK432-activated natural killer cells enhanced trastuzumab (Herceptin)-mediated antibody-dependent cellular cytotoxicity in patients with advanced cancer.

Sudo T, Aruga A, Shimizu K, Matsushita N, Takasaki K. Sudo T, et al. Among authors: aruga a. Anticancer Res. 2006 Nov-Dec;26(6B):4327-33. Anticancer Res. 2006. PMID: 17201151 Free article.

9

[The analysis of CCR4+/CXCR3+ cell ratio in gastrointestinal cancer patients receiving chemotherapy or immunotherapy].

Sakuyama R, Aruga A, Kuramochi H, Matsushita N, Kotera Y, Takeshita S, Hayashi K, Yamamoto M. Sakuyama R, et al. Among authors: aruga a. Gan To Kagaku Ryoho. 2008 Nov;35(12):2259-61. Gan To Kagaku Ryoho. 2008. PMID: 19106589 Japanese.

10

[The case of tumor escape mechanism by changing their tumor-associated antigens].

Suzuki R, Kotera Y, Takeshita N, Matsushita N, Okuyama R, Aruga A, Yamamoto M. Suzuki R, et al. Among authors: aruga a. Gan To Kagaku Ryoho. 2009 Nov;36(12):1988-90. Gan To Kagaku Ryoho. 2009. PMID: 20037300 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters